Pfizer is working on an oral, antiviral medication that could be taken at home to reduce the severity of COVID-19 symptoms. The drug is entering the next stage of clinical trials and could become an important tool in reducing the severity of disease in people who have a coronavirus infection. It could also be a lifeline for those who are unable to receive COVID-19 vaccines, which will remain the primary preventative measure in the pandemic.